When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Vaxart (NASDAQ: VXRT) isn't as well-known as other coronavirus vaccine makers. However, the small biotech stock emerged as a huge winner in 2020. Vaxart is currently evaluating its tablet COVID-19 vaccine in an early stage clinical study. In this Motley Fool Live video recorded on Jan. 6, 2021, Healthcare and Cannabis Bureau Chief Corinne Cardina and Fool.com writer Keith Speights answer a viewer's question about whether or not investors should buy Vaxart stock now.